uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Enpaxiq
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004193
ATC code
L01XE
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of myelofibrosis
MeSH:
Primary Myelofibrosis
Group:
Antineoplastic agents
Marketing Authorisation Holder
CTI Life Sciences Limited
MAH
Enpaxiq | uMedical